Biogen (BIIB) earnings Q4 2024
Biogen, a leading biotechnology company focused on developing treatments for neurological and autoimmune diseases, reported its earnings for the fourth quarter of 2024 on Thursday. The company’s performance exceeded expectations, driven by strong sales of… Biogen (BIIB) earnings Q4 2024